330.50MMarket Cap-4.15P/E (TTM)
7.030High6.480Low278.92KVolume6.740Open6.780Pre Close1.93MTurnover1.09%Turnover RatioLossP/E (Static)47.21MShares27.72052wk High2.79P/B179.32MFloat Cap5.81052wk Low--Dividend TTM25.62MShs Float35.000Historical High--Div YieldTTM8.11%Amplitude4.545Historical Low6.912Avg Price1Lot Size
Silence Therapeutics Stock Forum
Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
Silence Therapeutics presented additional Phase 1 results for divesiran in polycythemia vera (PV) patients at the ASH Annual Meeting. The SANRECO study data showed substantial reduction in phlebotomy frequency and lower hematocrit levels in 19 PV patients. Following treatment, only five phlebotomies were required during t...
$Rezolve AI (RZLV.US)$ Alot of short shares sold this month and in September. Reversal should be starting now that it has reached $1.63. First climb will be to 4.70 with that PT being at the end of December. February's PT will be 12.00. Partnerships with Microsoft and Google will push it until they re...
No comment yet